| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4ace46170a1b4905c5ad2dddcb7ac3db
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1721d75f5bf603447ec5a26b5c1c0be0 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-14 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5517
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-04 |
| filingDate |
2017-08-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d72acac7743af936dcf37f2e973824d7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cb7d3cc28607619de4878cc2ad91ecb4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_996495ed7a71ae738e51971b4d110d73
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_233d3797ae6f3f3e858f626071136437
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_14c3d66d1c78dd51ee6168f416e47f82
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_752a91d721b97463a06d0fcc78e3c19d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7e73be0eed8b8746a329a952d0d4bcb0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_327dea86123a78d3613299970798083e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_93095d0542c07acbef82861158b7a1f9 |
| publicationDate |
2018-02-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2018035246-A1 |
| titleOfInvention |
Gaba(a) receptor modulators and methods to control airway hyperresponsiveness and inflammation in asthma |
| abstract |
Pyrrolobenzodiazepines target alpha-4 and alpha-5 GABA A receptors for use in the treatment of airway hyperresponsiveness and inflammation in asthma. Compounds selectively partition to the peripheral compartment and have reduced CNS effects. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021198124-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021213952-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11739095-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3901155-A1 |
| priorityDate |
2016-08-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |